Next Generation News and Research

RSS

Computer simulation shows how evolution may have speeded up

Is heading straight for a goal the quickest way there? If the name of the game is evolution, suggests new research at the Weizmann Institute of Science, the pace might speed up if the goals themselves change continuously.

28 Aug 2007

Scientist uses novel mass spectrometer to weigh virus particle

With unprecedented sensitivity, Carnegie Mellon University's Mark Bier has characterized large viral particles and bulky von Willebrand factors using a novel mass spectrometer.

24 Aug 2007

Breakthrough pain medication

Cancer patients frequently experience two types of pain: persistent and breakthrough.

17 Aug 2007

Bcl-3 protein regulates inflammation by blocking ubiquitination

Researchers at the University of Pennsylvania School of Medicine recently identified how a regulatory protein called Bcl-3 helps to control the body's inflammation response to infection by interfering a critical biochemical process called ubiquitination.

8 Aug 2007

New tool for use in addressing lead poisoning

Lead in goat blood might not be on the top of your shopping list, but for U.S. medical personnel who each year perform more than 2 million human blood measurements, Standard Reference Material (SRM) 955c from the National Institute of Standards and Technology (NIST) can't be beat.

6 Aug 2007

Discovery of molecular pathway that detects and eliminates defective messenger RNAs from red blood cells

Other such pathways - known as surveillance pathways - operate in a more general way, in many cell types. Knowing how this specific surveillance system works can help researchers better understand hereditary diseases, in this case, thalassemia, a form of anemia, which is the most common genetic disorder worldwide.

3 Aug 2007

Active management of risk in pregnancy lowers Cesarean rates

At a time when national rates of cesarean delivery have climbed above 30%, a four-year study of patients receiving an alternative method of obstetric care experienced a significantly lower rate of cesarean births, according to a study published in the current issue of the Annals of Family Medicine .

1 Aug 2007

FDA approves Demipulse and Demipulse Duo Generators for use in vagus nerve stimulation

Cyberonics, Inc. has announced that the Demipulse and Demipulse Duo Generators for use in Vagus Nerve Stimulation ("VNS") Therapy were approved by the United States Food and Drug Administration ("FDA") for commercial release.

17 Jul 2007

New target for muscular dystrophy drug therapy

Researchers at the University of Pennsylvania School of Medicine report how the gene for utrophin, which codes for a protein very similar to dystrophin, the defective protein in Duchenne muscular dystrophy (DMD), puts the brakes on its own expression in muscle cells, thereby suggesting a new target for treatment.

13 Jul 2007

Wilmot Cancer Center studies new chemo pill for lymphoma

Doctors at the University of Rochester's James P. Wilmot Cancer Center are first in the world to study a new, targeted agent that zeroes-in on B-cell lymphomas. The new twice-a-day pill offers patients with recurrent disease another choice as their options grow thin.

12 Jul 2007

Microchip Biotechnologies secures patent rights from Pathwork Diagnostics

Microchip Biotechnologies, Inc. has announced that it has secured key patent rights from Pathwork Diagnostics for sample injection structures in microfluidic separations.

12 Jul 2007

Next generation painkillers

Scientists studying one of nature's simplest organisms have helped to unravel the structure of a key molecule that controls pain in humans.

From The University of Manchester 12 Jul 2007

Court rules in favor of Massachusetts Eye and Ear Infirmary

The Massachusetts Eye and Ear Infirmary (MEEI) has announced that the United States District Court for the District of Massachusetts, Judge William G. Young, following a Nov. 6, 2006 jury decision, ruled in favor of MEEI on claims of unjust enrichment and unfair trade practices against QLT Inc.

11 Jul 2007

Etravirine effective for HIV supression

Treatment with TMC125 (etravirine) leads to better virological suppression than placebo as part of antiretroviral therapy in patients with documented resistance to non-nucleoside reverse transcriptase inhibitors (NNRTIs), conclude two randomised trials in this week's issue of The Lancet.

8 Jul 2007

OncoLife web-based cancer survivorhip care plan

A team of cancer specialists from OncoLink.org, the award-winning cancer Web-based resource of the Abramson Cancer Center of the University of Pennsylvania, has launched OncoLife, the first and only individualized plan-of-care based on the national Institute of Medicine's recommendations for adult cancer survivors.

4 Jul 2007